Pennock, Gregory K <br/><br/>
The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.  [electronic resource] 

 -  The oncologist  Jul 2015 
 - 812-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2014-0422  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized--immunology<br/>Antigens, CD--immunology<br/>Antineoplastic Agents--adverse effects<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Humans<br/>Immunotherapy--methods<br/>Ipilimumab<br/>Melanoma--drug therapy<br/>Molecular Targeted Therapy<br/>Neoplasms--drug therapy<br/>Programmed Cell Death 1 Receptor--immunology<br/>T-Lymphocytes--immunology<br/>Lymphocyte Activation Gene 3 Protein